Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-15

Clinical Trial Update: Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on local treatment (stereotactic body radiotherapy and surgery) for estrogen receptor–positive, HER2-negative oligo-metastatic bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: UNKNOWN